Overview
Alveogyl (Septodont, Saint-Maur-des-Fossés - France) is a Medical Device used as dressing in case of dry socket.
ALVE study is a clinical investigation measuring Alveogyl performance and safety in patients with post-extraction dry socket.
The study takes place in India and in France where Alveogyl is already marketed, since 2010 in France and since 2014 in India .
Eligibility
Inclusion Criteria:
- Male or female patient, adult or child
- Positive diagnosis of dry socket occurring after the extraction of a permanent tooth (mature or immature)
- Signed informed consent
- In France only :Patient affiliated to a Health Insurance Scheme ("sécurité sociale")
Exclusion Criteria:
- Spreading infection in the alveolar socket
- Placement of Alveogyl done immediately after tooth extraction
- Multiple post-extraction dry sockets
- Patient treated with cervico-facial radiotherapy
- Immunodeficiency related to any diseases or current treatments
- Psychiatric patient or patient unable to assess his/her pain via the study Pain VAS
- Patient with history of hypersensitivity to one of the components
- Patient on post extraction of deciduous teeth
- Participation in another clinical investigation